- Investing Ideas
- Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
Fidson Healthcare
Market Cap: ₦327.6b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦136.50
7D
0%
1Y
390.1%
May & Baker Nigeria
Market Cap: ₦80.6b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦46.70
7D
-6.6%
1Y
295.8%